United States Sleep Apnea Device Market Insights Forecasts to 2033

• The U.S. Sleep Apnea Device Market Size Was valued at USD 1.95 Billion in 2023.
• The Market is Growing at a CAGR of 7.07% from 2023 to 2033
• The U.S. Sleep Apnea Device Market Size is expected to reach USD 3.86 Billion by 2033

The United States Sleep Apnea Device Market is anticipated to exceed USD 3.86 Billion by 2033, growing at a CAGR of 7.07% from 2023 to 2033. The growing prevalence of sleep apnea, rising awareness, and technological advancements are driving the growth of the sleep apnea device market in the US.     

Market Overview

Sleep apnea devices are used to eliminate snoring and prevent sleep apnea. Sleep apnea is a sleep disorder characterized by periodic interruption of breathing during sleep. It is often an underdiagnosed condition that may be caused due to excess weight and an unhealthy modern lifestyle. In the US, sleep apnea is correctly diagnosed in over 5.8 million adult patients. There is a rising development of effective and safe sleep apnea diagnosis and treatment alternatives by medical professionals. Businesses constantly invest in R&D to enhance the usability, comfort, and efficacy of their devices. Collaborating and forming partnerships with healthcare providers and technological innovators are increasingly common strategies for broadening market reach and offering all-encompassing solutions. Furthermore, the shift in healthcare toward home-based treatment increases long-term treatment plan adherence and compliance that helps to manage diseases without frequent hospital stays or clinic visits.  

Report Coverage

This research report categorizes the market for the US sleep apnea device market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States sleep apnea device market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the US sleep apnea device market.

Driving Factors

The growing frequency of obstructive sleep apnea (OSA) diagnoses and the release of sophisticated, user-friendly products are driving up the US sleep apnea device market. The increasing aging population in the US which is at the highest risk of developing this disorder is anticipated to propel the market demand. The continuous investment in R&D for improving device efficacy and use is further contributing to market growth. Furthermore, the strategies of collaborations and partnerships with healthcare providers and technological innovators are expanding the market. In addition, the growing prevalence of obesity and hypertension along with increasing awareness among the patients are responsible for propelling the market growth.   

Restraining Factors

A significant portion of the population is discouraged from using sleep apnea devices due to the expensive cost of the treatment devices, thereby restraining the US sleep apnea devices market.

Market Segmentation

The United States Sleep Apnea Device Market share is classified into diagnostic devices and end user.

• The pulse oximeter segment is anticipated to grow at the fastest pace during the forecast period.

The United States sleep apnea device market is segmented by diagnostic devices into polysomnography devices, pulse oximeter, actigraphy monitoring device, respiratory polygraph, and sleep apnea screening devices. Among these, the pulse oximeter segment is anticipated to grow at the fastest pace during the forecast period. Pulse oximeter devices are used to monitor the oxygen saturation in blood. The ongoing developments, product launches and partnerships, and collaboration strategies are the factors responsible for propelling the market growth.

• The home care settings/individuals segment dominates the US sleep apnea device market during the forecast period.

The United States sleep apnea device market is segmented by end user into sleep laboratories, clinics, & hospitals and home care settings/individuals. Among these, the home care settings/individuals segment dominates the US sleep apnea device market during the forecast period. Technological advancements have led to the development of sleep apnea devices that are more lightweight, easy to use, and silent, making them ideal for use at home. The consumer desire for homecare settings, motivated by the increased comfort and convenience are driving the market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the U.S. sleep apnea device market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• ResMed Inc.
• Somnomed
• Compumedics
• Koninklijke Philips N.V.
• Natus Medical Incorporated
• Carefusion Corp
• Teleflex Incorporated
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)
•  

Recent Developments

• In February 2024, ResMed unveiled the latest addition to its slate, announcing the launch of a new bi-level respiratory support device that would give doctors another option for treating their patients with sleep apnea beyond the segment-dominating CPAP machines.

• In April 2024, Fisher & Paykel Healthcare Corporation Limited announced the launch of the F&P Solo Nasal mask in the USA for the treatment of obstructive sleep apnea (OSA).

• In November 2023, Vivos Therapeutics announced it received FDA 510(k) clearance for its line of Complete Airway Repositioning and/or Expansion (CARE) oral appliances for the treatment of severe obstructive sleep apnea (OSA).

Market Segment

This study forecasts revenue at U.S., regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United States Sleep Apnea Device Market based on the below-mentioned segments:

US Sleep Apnea Device Market, By Diagnostic Devices

• Polysomnography Devices
• Pulse Oximeter
• Actigraphy Monitoring Device
• Respiratory Polygraph
• Sleep Apnea Screening Devices

US Sleep Apnea Device Market, By End User

• Sleep Laboratories, Clinics, & Hospitals
• Home Care Settings/Individuals